Delivering Digital Engagement Platforms for Complex Therapeutic Areas 

We often work with global pharma leaders who aren’t starting from scratch, but are expanding, refining, and strengthening how they engage online.  

These companies already have a wealth of scientific knowledge, established reputations, and loyal audiences. What they seek from us is to build open source digital platforms that make their knowledge accessible and impactful, and, just as importantly, reveal what resonates most with their customers. Not traditional campaign sites, but platforms that will act as lasting, user-friendly anchors for healthcare professionals (HCPs) and patients to learn at their own pace, revisit trusted content anytime, and explore the topics that matter most to them. 

This case study tells the story of two such collaborations.  

One, a European-based specialty care powerhouse advancing treatments in oncology and neuroscience. The other, a global healthcare leader known for its widely used medicines and devices. Though different in scale and therapeutic focus, they shared a clear objective: to give their audiences reliable digital spaces, and to see what they’re interested in. 

They turned to Viseven for our experience delivering platform-based healthcare ecosystems that balance scientific accuracy, compliance, and user-centric design. What followed were two projects that looked different on the surface, yet were driven by the same principle — when access becomes easier, healthcare communication becomes stronger. 

Understanding the Challenges Behind Each Project 

While both companies set out to build digital engagement platforms, the challenges they faced reflected their distinct focus areas and audiences. 

European-based biopharma company 

Focused on oncology, rare diseases, and neuroscience, this company needed to expand its digital footprint across highly complex therapeutic areas. Its goal was to deliver accurate, disease-specific knowledge to healthcare professionals and patients without barriers like logins or gated content.  

This meant designing open-access digital platforms that could communicate complex science clearly, support continuous medical education, and offer trusted resources to people navigating conditions such as kidney and liver cancer or spasticity-related movement disorders. 

Global healthcare products company 

With a widely used nonsteroidal anti-inflammatory drug, this global healthcare technology leader wanted to modernize how they engaged patients and HCPs around a single, well-established product. Outdated and fragmented content across markets was eroding clarity and reach. 

They needed a centralized, compliant platform that would present product information in a clear, user-friendly format, including indications, safety guidance, and educational resources, and help reinforce brand trust through consistent healthcare communication. 

How We Planned and Delivered the Platforms 

The projects followed the same structured process to ensure quality, compliance, and long-term maintainability. 

Project scope and responsibilities 

Each project involved developing public-facing digital engagement platforms on WordPress CMS, designed to be intuitive for both HCP and patient audiences.  

We set up content architectures tailored to their distinct needs, ensured mobile and SEO optimization, and integrated third-party services where needed, including CRM systems for user tracking, analytics for behavioral insights, and webinar platforms and medical content providers to enrich user experience.  

Beyond development, our team provided full post-launch maintenance, server setup, and hosting. 

Delivery approach and methodology 

We began with a preparation and alignment phase, working closely with stakeholders to define business goals, user groups, and content structure. Development followed an agile model, with iterative sprints, regular demos, and feedback sessions that kept all teams aligned. 

Throughout the build, we carried out extensive quality assurance, combining automated and manual functional testing with performance, security, and cross-device checks. Before go-live, we conducted User Acceptance Testing (UAT) alongside client teams to confirm that every requirement, including regulatory ones, was met. 

Deployment was managed as a coordinated release across environments, supported by comprehensive technical documentation (from platform architecture and API specifications to deployment guides and admin-side user manuals). Throughout the process, collaboration stayed transparent and predictable:  

• weekly alignment meetings 
• sprint reviews 
• daily coordination through Jira and Microsoft Teams 

Creating Lasting Platforms for Engagement 

Rather than applying a one-size-fits-all template, we approached both projects as distinct ecosystems shaped around their audiences and content goals. We focused on three core principles: removing barriers to access, structuring content to support different levels of medical expertise, and embedding data analytics to show what resonates. 

European biopharmaceutical company 

For this company, we developed a network of three public-facing portals focused on complex therapeutic areas: 

1. kidney cancer 
2. liver cancer 
3. spasticity-related movement disorders  

Each platform was designed to act as an accessible patient and HCP portal, providing clear educational content, clinical insights, and real-world perspectives. 

The oncology portals offered structured information on disease symptoms, diagnostic pathways, and treatment options, complemented by expert interviews, patient stories, and visual explainers that simplified complex medical concepts.  

The neuroscience portal focused on patient-centered storytelling, emotional support, and consultation preparation tools to encourage open dialogue between patients and HCPs, and caregivers.  

All three hubs were built to be mobile-friendly, SEO-optimized, and aligned with regulatory requirements, ensuring consistent quality and reach across audiences. 

Global healthcare products company 

For this leading life sciences company, we created a modern, responsive website dedicated to one of their well-known nonsteroidal anti-inflammatory drugs. The platform consolidated previously fragmented information and presented it in a user-friendly, compliant format. 

The site provides clear explanations of the product’s indications (osteoarthritis, rheumatoid arthritis, back pain, and menstrual pain), its mechanism of action as an NSAID, and proper dosage and safety guidance.  

It contains FAQs, downloadable patient leaflets, and links to official prescribing information, ensuring both patients and doctors have legit resources in one place. As with the first client’s platforms, the site was built with SEO and accessibility best practices and fully optimized for mobile use. 

How the Platforms Changed Engagement 

The platforms quickly became central to how both companies communicate with their audiences.  

For the teams behind them, having structured, accessible content available on demand removed the friction of one-off requests, PDF sharing, and manual follow-ups. 

Healthcare professionals and patients could now explore information independently, while the companies could see which topics held their attention and where they dropped off. These commercial analytics are now feeding into their digital healthcare strategies, shaping future content planning around actual user behavior rather than assumptions. 

Operationally, the shift to open-source digital platforms reduced reliance on printed brochures, in-person events, and field teams for routine information delivery. Internal teams were able to redirect their time from repetitive tasks to strategic initiatives, and content managers could update materials centrally without developer involvement. 

Through the clients’ eyes 

In their feedback, both teams focused less on the features themselves and more on how the work unfolded.  

They said our team quickly grasped the context around each platform: who it was for, how it needed to align with internal rules, and where it fit into their wider digital plans. They also noted that the platforms worked reliably from the start and didn’t disrupt their existing systems, which eased the launch process.  

What they brought up most often, though, was the pace and clarity of collaboration: regular check-ins, quick responses, and the willingness to adjust.